• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Nrf-2和ABCG2的高表达与肺癌SP细胞的多药耐药性有关。

Elevated Expression of Nrf-2 and ABCG2 Involved in Multi-drug Resistance of Lung Cancer SP Cells.

作者信息

Yang B, Ma Y-F, Liu Y

机构信息

Department of Thoracic Surgery, Chinese PLA General Hospital, Beijing, China.

出版信息

Drug Res (Stuttg). 2015 Oct;65(10):526-31. doi: 10.1055/s-0034-1390458. Epub 2014 Nov 4.

DOI:10.1055/s-0034-1390458
PMID:25368906
Abstract

BACKGROUND

Over expression of ATP-binding cassette (ABC) transporter protein (ABCG2) in side population cells plays a crucial role in the chemotherapeutic drug efflux. Constitutive expression of redox sensing transcritption factor Nrf2 was shown to be involved in regulation of ABCG2 expression and chemoresistance. In the current study we made an attempt to characterize the lung adenocarcinoma SP cells.

MATERIALS AND METHODS

We used FACs based Hoechst 33342 dye exclusion assay for purification of lung cancer SP cells. The sorted SP cells were subjected to drug resistance, sphere formation assays and gene expression analysis (Nrf2 and ABCG2).

RESULTS

We have identified 2.9% of SP cells from lung cancer whose prevalence is significantly reduced to 0.3% upon treatment with verapamil. RT-PCR and western blot analysis revealed that Nrf2 and ABCG2 were highly expressed in lung cancer SP cells. Further, these SP cells are resistant to several chemotherapeutic drugs, self-renewal, and highly tumorigenic than non-SP cells.

CONCLUSIONS

Our data suggest that Nrf2-mediated ABCG2 over expression in lung adenocarcinoma SP cells might responsible for chemotherapy failure. Therefore, designing novel anticancer drugs that attenuates the Nrf2 and ABCG2 expression, makes SP cells more sensitive to chemotherapy and thus prevent the tumor relapse.

摘要

背景

三磷酸腺苷结合盒(ABC)转运蛋白(ABCG2)在侧群细胞中的过表达在化疗药物外排中起关键作用。氧化还原感应转录因子Nrf2的组成性表达被证明参与ABCG2表达的调节和化疗耐药性。在本研究中,我们试图对肺腺癌侧群细胞进行特征描述。

材料与方法

我们使用基于荧光激活细胞分选术(FACs)的Hoechst 33342染料排除法纯化肺癌侧群细胞。对分选得到的侧群细胞进行耐药性、成球试验和基因表达分析(Nrf2和ABCG2)。

结果

我们从肺癌中鉴定出2.9%的侧群细胞,用维拉帕米处理后其比例显著降至0.3%。逆转录聚合酶链反应(RT-PCR)和蛋白质免疫印迹分析显示,Nrf2和ABCG2在肺癌侧群细胞中高表达。此外,这些侧群细胞对几种化疗药物具有耐药性、自我更新能力,且比非侧群细胞具有更高的致瘤性。

结论

我们的数据表明,肺腺癌侧群细胞中Nrf2介导的ABCG2过表达可能是化疗失败的原因。因此,设计能减弱Nrf2和ABCG2表达的新型抗癌药物,可使侧群细胞对化疗更敏感,从而防止肿瘤复发。

相似文献

1
Elevated Expression of Nrf-2 and ABCG2 Involved in Multi-drug Resistance of Lung Cancer SP Cells.Nrf-2和ABCG2的高表达与肺癌SP细胞的多药耐药性有关。
Drug Res (Stuttg). 2015 Oct;65(10):526-31. doi: 10.1055/s-0034-1390458. Epub 2014 Nov 4.
2
Expression of ABCG2 (BCRP) is regulated by Nrf2 in cancer cells that confers side population and chemoresistance phenotype.ABCG2(BCRP)的表达受癌细胞中 Nrf2 的调节,赋予其侧群和化疗耐药表型。
Mol Cancer Ther. 2010 Aug;9(8):2365-76. doi: 10.1158/1535-7163.MCT-10-0108. Epub 2010 Aug 3.
3
ABCG2-meditated multidrug resistance and tumor-initiating capacity of side population cells from colon cancer.ABCG2 介导的结肠癌侧群细胞的多药耐药性和肿瘤起始能力。
Oncol Res Treat. 2014;37(11):666-8, 670-2. doi: 10.1159/000368842. Epub 2014 Oct 17.
4
Abnormal Wnt signaling and overexpression of ABCG2 contributes to drug efflux properties of side population cells in nasopharyngeal carcinoma.异常的Wnt信号传导和ABCG2的过表达有助于鼻咽癌中侧群细胞的药物外排特性。
Mol Med Rep. 2015 Sep;12(3):4352-4357. doi: 10.3892/mmr.2015.3935. Epub 2015 Jun 16.
5
Cholesterol reduces the sensitivity to platinum-based chemotherapy via upregulating ABCG2 in lung adenocarcinoma.胆固醇通过上调肺腺癌中的ABCG2降低对铂类化疗的敏感性。
Biochem Biophys Res Commun. 2015 Feb 20;457(4):614-20. doi: 10.1016/j.bbrc.2015.01.035. Epub 2015 Jan 17.
6
Hedgehog signaling regulates drug sensitivity by targeting ABC transporters ABCB1 and ABCG2 in epithelial ovarian cancer.刺猬信号通路通过靶向上皮性卵巢癌中的ABC转运蛋白ABCB1和ABCG2来调节药物敏感性。
Mol Carcinog. 2014 Aug;53(8):625-34. doi: 10.1002/mc.22015. Epub 2013 Feb 19.
7
Downregulated ABCG2 enhances sensitivity to topoisomerase I inhibitor in epidermal growth factor receptor tyrosine kinase inhibitor-resistant non-small cell lung cancer.下调 ABCG2 可增强表皮生长因子受体酪氨酸激酶抑制剂耐药的非小细胞肺癌对拓扑异构酶 I 抑制剂的敏感性。
J Thorac Oncol. 2010 Nov;5(11):1726-33. doi: 10.1097/JTO.0b013e3181f0b6af.
8
The multidrug resistance transporter ABCG2 (breast cancer resistance protein 1) effluxes Hoechst 33342 and is overexpressed in hematopoietic stem cells.多药耐药转运蛋白ABCG2(乳腺癌耐药蛋白1)可外排Hoechst 33342,且在造血干细胞中过表达。
Clin Cancer Res. 2002 Jan;8(1):22-8.
9
Pelitinib (EKB-569) targets the up-regulation of ABCB1 and ABCG2 induced by hyperthermia to eradicate lung cancer.佩利替尼(EKB-569)靶向高温诱导的ABCB1和ABCG2上调,以根除肺癌。
Br J Pharmacol. 2015 Aug;172(16):4089-106. doi: 10.1111/bph.13189. Epub 2015 Jun 26.
10
Low molecular weight heparin ablates lung cancer cisplatin-resistance by inducing proteasome-mediated ABCG2 protein degradation.低分子量肝素通过诱导蛋白酶体介导的 ABCG2 蛋白降解来消除肺癌顺铂耐药性。
PLoS One. 2012;7(7):e41035. doi: 10.1371/journal.pone.0041035. Epub 2012 Jul 23.

引用本文的文献

1
Clinical relevance of stem cells in lung cancer.干细胞在肺癌中的临床相关性。
World J Stem Cells. 2023 Jun 26;15(6):576-588. doi: 10.4252/wjsc.v15.i6.576.
2
Impact of Cancer Stem Cells and Cancer Stem Cell-Driven Drug Resiliency in Lung Tumor: Options in Sight.癌症干细胞及癌症干细胞驱动的肺癌耐药性的影响:现有选择
Cancers (Basel). 2022 Jan 6;14(2):267. doi: 10.3390/cancers14020267.
3
Anlotinib suppresses metastasis and multidrug resistance dual blockade of MET/ABCB1 in colorectal carcinoma cells.安罗替尼抑制结直肠癌细胞中MET/ABCB1的转移和多药耐药双重阻断。
J Cancer. 2021 Feb 16;12(7):2092-2104. doi: 10.7150/jca.45618. eCollection 2021.
4
Methyl-Cantharidimide (MCA) Has Anticancer Efficacy in ABCB1- and ABCG2-Overexpressing and Cisplatin Resistant Cancer Cells.甲基斑蝥酰亚胺(MCA)对过表达ABCB1和ABCG2且耐顺铂的癌细胞具有抗癌功效。
Front Oncol. 2020 Jun 26;10:932. doi: 10.3389/fonc.2020.00932. eCollection 2020.
5
VS-4718 Antagonizes Multidrug Resistance in ABCB1- and ABCG2-Overexpressing Cancer Cells by Inhibiting the Efflux Function of ABC Transporters.VS-4718通过抑制ABC转运蛋白的外排功能来拮抗ABCB1和ABCG2过表达癌细胞中的多药耐药性。
Front Pharmacol. 2018 Oct 30;9:1236. doi: 10.3389/fphar.2018.01236. eCollection 2018.
6
Selonsertib (GS-4997), an ASK1 inhibitor, antagonizes multidrug resistance in ABCB1- and ABCG2-overexpressing cancer cells.根据阿克 1 抑制剂塞尔索替尼(GS-4997),可拮抗 ABCB1 和 ABCG2 过表达的癌细胞中的多药耐药性。
Cancer Lett. 2019 Jan;440-441:82-93. doi: 10.1016/j.canlet.2018.10.007. Epub 2018 Oct 10.
7
Changes of and /NF-B Expression Levels Induced by Cell-Free DNA in Different Cell Types.不同细胞类型中无细胞游离 DNA 诱导的和 /NF-B 表达水平的变化。
Oxid Med Cell Longev. 2018 Mar 20;2018:1052413. doi: 10.1155/2018/1052413. eCollection 2018.
8
Identification of side population cells in human lung adenocarcinoma A549 cell line and elucidation of the underlying roles in lung cancer.人肺腺癌A549细胞系中侧群细胞的鉴定及其在肺癌中的潜在作用解析
Oncol Lett. 2018 Apr;15(4):4900-4906. doi: 10.3892/ol.2018.7956. Epub 2018 Feb 5.
9
NRF2 Is a Potential Modulator of Hyperresistance to Arsenic Toxicity in Stem-Like Keratinocytes.NRF2 是干细胞样角质细胞砷毒性超抗性的潜在调节剂。
Oxid Med Cell Longev. 2017;2017:7417694. doi: 10.1155/2017/7417694. Epub 2017 Sep 10.
10
Elevated expression of Nrf2 mediates multidrug resistance in CD133 head and neck squamous cell carcinoma stem cells.Nrf2的高表达介导CD133头颈部鳞状细胞癌干细胞中的多药耐药性。
Oncol Lett. 2016 Dec;12(6):4333-4338. doi: 10.3892/ol.2016.5269. Epub 2016 Oct 17.